Definitive Contract HDTRA117C0070
Award Date 8/28/17
Potential Completion Date 10/27/23
Potential Value $20M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Malvern, PA 19355, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Venatorx Pharmaceuticals Inc. was awarded a definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Biomedical Advanced Research and Development Authority (BARDA) program with a ceiling value of approximately $147.5 million. The contract, awarded on July 17, 2019, with an ultimate completion date of September 30, 2025, supports the advanced research and development of medical countermeasures against chemical, biological, radiological, and...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a definitive cost-plus-no-fee contract to Pfizer Inc. for innovative treatments addressing multidrug-resistant infections. The contract, valued at approximately $94.7 million with an ultimate completion date of September 30, 2025, was originally awarded on September 15, 2015. Modification P00013 constitutes a de-obligation of funds, reducing the active contract value....
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $15,505,000.31 definitive cost-no-fee contract to Entasis Therapeutics Inc., a subsidiary of Innoviva, Inc., to identify and develop a non-beta-lactam penicillin-binding protein (PBP) inhibitor with broad-spectrum activity against multidrug-resistant Gram-negative ESKAPE pathogens. This work directly responds to a NIAID solicitation for proposals addressing...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract worth $81,658.26 to Pfizer Inc. (Pfizer) for the supply of 4,553,985,965 units of Vancomycin 1,000 mg intravenous injection. This contract, awarded on June 25, 2021 with a completion date of June 30, 2021, is not designated as a set-aside. Pfizer, a global pharmaceutical corporation, serves as the prime contractor for this award. As a large business, Pfizer has previously been awarded...
- This is a $7,621,277 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Microbiotix, Inc., a clinical-stage biopharmaceutical company in Worcester, Massachusetts. The contract is to develop phenoxyacetamide T3SS inhibitors as adjunctive agents to antibacterial therapy for treating multidrug-resistant Pseudomonas aeruginosa infections. This work was originally solicited through a Broad Agency Announcement seeking proposals to develop...
- The Defense Logistics Agency awarded a $164,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mL bottles of 250mg/5mL penicillin VK oral solution. The contract has a period of performance from August 14-15, 2023, with all work to be conducted by the prime contractor at its facility in Conshohocken, Pennsylvania. This non-set aside award utilizes the Prime Vendor Program indefinite-delivery/indefinite-quantity contract to supply pharmaceutical products in support of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20 million unit vials of the antibiotic PFIZERPEN, with a ceiling value of $1,184.80. The contract is a firm fixed-price delivery order with a period of performance through July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- Vedanta Biosciences, Inc. was awarded a definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) on September 28, 2020, with a ceiling value of $114.1 million. The contract, which extends through December 31, 2031, is structured as a cost-sharing agreement with no set-aside designation. Under this award, Vedanta Biosciences will conduct clinical development of VE303, a live biotherapeutic product (LBP) designed to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,252,238 units of Penicillin G Potassium (Penicillin GK), a critical antibiotic medication. The $1,473.50 fixed-price delivery order has a completion date of July 26, 2024 and is not set aside for any specific business size or socioeconomic category. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award, identified as SPE2D020D0014|SPE2D324F169S, was issued by the Defense Logistics Agency Troop Support Medical (DLA Troop Support) to Pfizer Inc. as the prime contractor. The $2,888.46 firm fixed-price delivery order is for the supply of Penicillin G Benzathine Suspension, a critical antibiotic medication. The contract has an ultimate completion date of August 5, 2024. Pfizer, a large global pharmaceutical corporation, has secured several significant Indefinite Delivery...